In general, for patients who are managing both breast cancer and diabetes or who are struggling with significant weight gain, doctors might consider prescribing tirzepatide if the benefits outweigh the risks
GLP-1 Receptor agonists and kidney protection
It did find that the percentage of weight lost from muscle mass was similar between the groups, while the semaglutide group lost more mass overall
6,7,9 It has also been elucidated that other hormones produced by other pancreatic islet cells and the gut are crucial for maintaining metabolic homeostasis, in addition to insulin and glucagon
GLP-1 drugs are linked to a significantly higher risk of developing neovascular or wet age-related macular degeneration, according to new research
So for you as a user of these drugs, it means that youll get the same benefits from either Zepbound or Mounjaro, but it may be easier to get your hands on Zepbound if you do not have type 2 diabetes